138 related articles for article (PubMed ID: 7724024)
1. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
Rostoker G; Ben Maadi A; Remy P; Lang P; Lagrue G; Weil B
Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin A treatment for idiopathic membranous nephropathy.
Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L
Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for idiopathic membranous nephropathy: who can benefit?
Ruggenenti P; Chiurchiu C; Abbate M; Perna A; Cravedi P; Bontempelli M; Remuzzi G
Clin J Am Soc Nephrol; 2006 Jul; 1(4):738-48. PubMed ID: 17699281
[TBL] [Abstract][Full Text] [Related]
4. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial.
Szeto CC; Chow KM; Kwan BC; Chung KY; Leung CB; Li PK
Am J Kidney Dis; 2008 May; 51(5):724-31. PubMed ID: 18436082
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
6. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
Hay U; Ludvik B; Gisinger C; Schernthaner G
Schweiz Med Wochenschr; 1988 Feb; 118(5):165-9. PubMed ID: 3278375
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy.
Kibriya MG; Tishkov I; Nikolov D
Nephrol Dial Transplant; 1994; 9(2):138-43. PubMed ID: 8190328
[TBL] [Abstract][Full Text] [Related]
8. [The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis].
Erley CM; Komini E; Nicaeus T; Braun N; Wolf S; Risler T
Dtsch Med Wochenschr; 1994 Jan; 119(4):89-95. PubMed ID: 8299527
[TBL] [Abstract][Full Text] [Related]
9. Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.
Gansevoort RT; Heeg JE; Vriesendorp R; de Zeeuw D; de Jong PE
Nephrol Dial Transplant; 1992; 7 Suppl 1():91-6. PubMed ID: 1337189
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy.
Buemi M; Allegra A; Corica F; Aloisi C; Giacobbe M; Pettinato G; Corsonello A; Senatore M; Frisina N
Clin Pharmacol Ther; 2000 Apr; 67(4):427-31. PubMed ID: 10801253
[TBL] [Abstract][Full Text] [Related]
11. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
Masunaga Y; Tabei K; Takeda S; Ando Y; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):961-6. PubMed ID: 8255007
[TBL] [Abstract][Full Text] [Related]
12. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
Camacho Díaz JA; Giménez Llort A; García García L; Jiménez González R
An Esp Pediatr; 2001 Sep; 55(3):219-24. PubMed ID: 11676896
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
Boumpas DT; Tassiulas IO; Fleisher TA; Vaughan E; Piscitelli S; Kim Y; Pucino F; Balow JE; Austin HA
Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
Eriguchi M; Oka H; Mizobuchi T; Kamimura T; Sugawara K; Harada A
Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
Haas M; Mayer G; Wirnsberger G; Holzer H; Ratschek M; Neyer U; Neuweiler J; Kramar R; Schneider B; Breiteneder-Geleff S; Regele HM; Hörl WH; Kerjaschki D
Wien Klin Wochenschr; 2002 Feb; 114(4):143-7. PubMed ID: 12060980
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Naumovic R; Jovanovic D; Pavlovic S; Stosovic M; Marinkovic J; Basta-Jovanovic G
Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
[TBL] [Abstract][Full Text] [Related]
17. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Willems HL; Wetzels JF
Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
[TBL] [Abstract][Full Text] [Related]
18. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
19. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
[TBL] [Abstract][Full Text] [Related]
20. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J
J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
